|
CREBL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.72740000081717E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.8405999470732E-09 |
| Normal-vs-Stage2 |
1.651990E-02 |
| Normal-vs-Stage3 |
5.834100E-04 |
| Normal-vs-Stage4 |
7.080300E-02 |
| Stage1-vs-Stage2 |
2.757200E-01 |
| Stage1-vs-Stage3 |
8.254000E-01 |
| Stage1-vs-Stage4 |
7.677000E-01 |
| Stage2-vs-Stage3 |
4.027400E-01 |
| Stage2-vs-Stage4 |
4.450400E-01 |
| Stage3-vs-Stage4 |
7.037000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.03670003084966E-09 |
| Normal-vs-AfricanAmerican |
8.224900E-03 |
| Normal-vs-Asian |
1.611180E-01 |
| Caucasian-vs-AfricanAmerican |
4.827800E-02 |
| Caucasian-vs-Asian |
8.583200E-01 |
| AfricanAmerican-vs-Asian |
4.343600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.02750005462838E-09 |
| Normal-vs-Female |
9.574500E-04 |
| Male-vs-Female |
2.292800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.73368999999424E-05 |
| Normal-vs-Extreme_Weight |
2.99819946647517E-10 |
| Normal-vs-Obese |
3.160300E-03 |
| Normal-vs-Extreme_Obese |
3.341900E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.960400E-01 |
| Normal_Weight-vs-Obese |
1.433010E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.858000E-01 |
| Extreme_Weight-vs-Obese |
2.806000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.407400E-01 |
| Obese-vs-Extreme_Obese |
1.354770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.40910000000239E-05 |
| Normal-vs-Age(41-60Yrs) |
5.74669999999777E-05 |
| Normal-vs-Age(61-80Yrs) |
3.92400001381077E-09 |
| Normal-vs-Age(81-100Yrs) |
3.348200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.342800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.544800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.784400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.030390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.847200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.465000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.02059999737858E-08 |
| Normal-VS-Type2 PRCC |
4.62899999997823E-06 |
| Normal-VS-KIRP CIMP |
9.61270000043868E-07 |
| Normal-VS-Unclassified PRCC |
3.629600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.592400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.129000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.165800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.378400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.394400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.068100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.52030000000192E-06 |
| Normal-vs-N1 |
7.903200E-03 |
| Normal-vs-N2 |
5.098600E-03 |
| N0-vs-N1 |
6.145600E-01 |
| N0-vs-N2 |
8.820000E-01 |
| N1-vs-N2 |
6.727000E-01 |
|
|
